Your browser doesn't support javascript.
loading
Assessing the benefit of the 72-hour antibiotic therapy reassessment documentation.
Pérut, V; Gauzit, R; Kernéis, S; Canouï, E; Chedhomme, F X; Batista, R; Conort, O; Bouam, S; Raymond, J; Loubinoux, J; Chevallier, A; Salmon-Ceron, D.
Affiliation
  • Pérut V; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de santé publique, unité de gestion des risques et qualité, hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014
  • Gauzit R; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Équipe mobile d'infectiologie, hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France.
  • Kernéis S; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Équipe mobile d'infectiologie, hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Faculté de médecine,
  • Canouï E; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Équipe mobile d'infectiologie, hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Faculté de médecine,
  • Chedhomme FX; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de pharmacie des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France.
  • Batista R; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de pharmacie des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France.
  • Conort O; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de pharmacie des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France.
  • Bouam S; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Unité d'information médicale, hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France.
  • Raymond J; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de bactériologie, hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France.
  • Loubinoux J; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de bactériologie, hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France.
  • Chevallier A; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de pharmacie des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France.
  • Salmon-Ceron D; Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Faculté de médecine, université Paris Descartes, Sorbonne Paris Cité, Paris, France; Service de maladies infectieuses, hôpitaux universitaires Paris c
Med Mal Infect ; 49(3): 187-193, 2019 May.
Article in En | MEDLINE | ID: mdl-30420165
ABSTRACT

OBJECTIVES:

To assess the documentation of the 72-hour antibiotic therapy reassessment in medical records.

METHODS:

One-day prevalence evaluation of curative antibiotic therapies≥72hours. The documentation of the reassessment was defined according to three criteria (1) "clear" documentation (clinical or microbiological comment associated with a comment on the need to adjust the antibiotic therapy or on the lack of need); (2) "tacit" documentation (only based on a clinical or microbiological comment); (3) no documentation.

RESULTS:

We assessed 114 antibiotic therapies in 26 hospital departments. A clear reassessment at 72hours was observed in only 45 (39%) records and 31 (27%) records had no reassessment. The planned duration of treatment was written in 63 (55%) records. At 72hours, among the 71 antibiotic therapies with a microbiological documentation, 69 (97%) were active and 44 (62%) had a narrow spectrum. Among the 48 antibiotic therapies with a broad spectrum on day 1, only 21 (44%) benefited from a de-escalation at 72hours. A clearly recorded reassessment at 72hours was associated with de-escalation (P=0.025) and the prescription of a planned duration of treatment was associated with antibiotic therapy compliance with local or national guidelines (P=0.018).

CONCLUSION:

Although reassessment was observed in 73% of records, it was correctly recorded at 72hours in only 39% of cases. The documentation of the reassessment and the prescription of a planned duration were associated with a better quality of antibiotic prescription (de-escalation, compliance with guidelines) and are relevant indicators for monitoring the proper use of antibiotics.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Medical Records / Drug Monitoring / Documentation / Anti-Bacterial Agents Type of study: Etiology_studies / Evaluation_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Med Mal Infect Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Medical Records / Drug Monitoring / Documentation / Anti-Bacterial Agents Type of study: Etiology_studies / Evaluation_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Med Mal Infect Year: 2019 Document type: Article
...